LeMaitre Vascular, Inc. (LMAT)
Market Cap | 1.82B |
Revenue (ttm) | 199.89M |
Net Income (ttm) | 33.95M |
Shares Out | 22.45M |
EPS (ttm) | 1.50 |
PE Ratio | 54.13 |
Forward PE | 43.79 |
Dividend | $0.64 (0.79%) |
Ex-Dividend Date | May 15, 2024 |
Volume | 82,988 |
Open | 80.33 |
Previous Close | 80.56 |
Day's Range | 79.90 - 81.92 |
52-Week Range | 44.27 - 84.15 |
Beta | 0.89 |
Analysts | Buy |
Price Target | 77.57 (-4.46%) |
Earnings Date | Jul 30, 2024 |
About LMAT
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The ... [Read more]
Financial Performance
In 2023, LMAT's revenue was $193.48 million, an increase of 19.69% compared to the previous year's $161.65 million. Earnings were $30.11 million, an increase of 45.89%.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is $77.57, which is a decrease of -4.46% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/j/g/conf20-2442552.jpg)
LeMaitre to Present at the Jefferies Global Healthcare Conference
BURLINGTON, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare ...
![](https://cdn.snapi.dev/images/v1/v/n/press15-2407578.jpg)
LeMaitre Q1 2024 Financial Results
BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024 results, announced a $0.16/share quarterly div...
![](https://cdn.snapi.dev/images/v1/w/h/press18-2380993.jpg)
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, afte...
![](https://cdn.snapi.dev/images/v1/y/c/conf2-2342855.jpg)
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference
BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needh...
![](https://cdn.snapi.dev/images/v1/u/q/conf8-2304535.jpg)
LeMaitre to Participate at Upcoming Investor Conferences in March
BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
![](https://cdn.snapi.dev/images/v1/3/2/press12-2296873.jpg)
LeMaitre Q4 2023 Financial Results
BURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2023 results, announced a $0.16/share quarterly di...
![](https://cdn.snapi.dev/images/v1/p/g/press12-2273808.jpg)
LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024
BURLINGTON, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024,...
![](https://cdn.snapi.dev/images/v1/j/o/conf1-2226445.jpg)
LeMaitre to Present at the 26th Annual Needham Growth Conference
BURLINGTON, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 26th Annual Needha...
![](https://cdn.snapi.dev/images/v1/w/z/conf6-2139984.jpg)
LeMaitre to Participate at Upcoming Investor Conferences in November
BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
![](https://cdn.snapi.dev/images/v1/s/l/press6-2134176.jpg)
LeMaitre Q3 2023 Financial Results
BURLINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2023 results, announced a $0.14/share quarterly di...
![](https://cdn.snapi.dev/images/v1/0/i/press6-2107709.jpg)
LeMaitre Will Announce Third Quarter 2023 Earnings Results November 1, 2023
BURLINGTON, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2023 financial results on Wednesday, November 1, 2023,...
![](https://cdn.snapi.dev/images/v1/j/x/conf3-2073692.jpg)
LeMaitre to Present at the 2023 Cantor Global Healthcare Conference
BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at 2023 Cantor Global Healthcare Conference on T...
![](https://cdn.snapi.dev/images/v1/f/f/press18-1999892.jpg)
LeMaitre Q2 2023 Financial Results
BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2023 results, announced a $0.14/share quarterly di...
![](https://cdn.snapi.dev/images/v1/l/k/conf3-1997754.jpg)
LeMaitre to Present at Upcoming Investor Conferences in August
BURLINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in August.
![](https://cdn.snapi.dev/images/v1/s/i/press12-1974889.jpg)
LeMaitre Will Announce Second Quarter 2023 Earnings Results August 1, 2023
BURLINGTON, Mass., July 17, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2023 financial results on Tuesday, August 1, 2023, af...
![](https://cdn.snapi.dev/images/v1/x/3/why-the-best-dividend-stocks-are-hated-by-analysts-1926162.jpg)
Why The Best Dividend Stocks Are Hated By Analysts
Analyst ratings are a wonderful contrarian indicator.
![](https://cdn.snapi.dev/images/v1/k/e/conf6-1923772.jpg)
LeMaitre to Present at Upcoming Investor Conferences in June
BURLINGTON, Mass., June 06, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in June.
![](https://cdn.snapi.dev/images/v1/w/r/press7-1866753.jpg)
LeMaitre Q1 2023 Financial Results
BURLINGTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2023 results, announced a $0.14/share quarterly div...
![](https://cdn.snapi.dev/images/v1/t/k/press14-1847117.jpg)
LeMaitre to Distribute Aziyo Biologics' Cardiovascular Patches
BURLINGTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, announced today it has entered into an agreement wi...
![](https://cdn.snapi.dev/images/v1/9/i/press12-1840547.jpg)
LeMaitre Will Announce First Quarter 2023 Earnings Results May 2, 2023
BURLINGTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2023 financial results on Tuesday, May 2, 2023, after...
![](https://cdn.snapi.dev/images/v1/f/y/press3-1795967.jpg)
LeMaitre to Go Direct in Thailand
BURLINGTON, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, today announced that it has signed a definitive agr...
![](https://cdn.snapi.dev/images/v1/9/c/press5-1768643.jpg)
LeMaitre Q4 2022 Financial Results
BURLINGTON, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2022 results, announced a $0.14/share quarterly di...
![](https://cdn.snapi.dev/images/v1/4/w/press4-1744291.jpg)
LeMaitre Will Announce Fourth Quarter 2022 Earnings Results February 23, 2023
BURLINGTON, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2022 financial results on Thursday, February 23, 2023...
![](https://cdn.snapi.dev/images/v1/j/q/conf5-1648030.jpg)
LeMaitre to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.
![](https://cdn.snapi.dev/images/v1/l/s/press15-1604415.jpg)
LeMaitre Q3 2022 Financial Results
BURLINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2022 results, announced a $0.125/share quarterly d...